Rockwell Medical Inc当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在药品行业排名96/158位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价3.75。中期看,股价处于下降通道。近一个月,市场表现一般,但基本面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
Rockwell Medical Inc评分
相关信息
行业排名
96 / 158
全市场排名
247 / 4582
所属行业
药品
压力支撑
由于公司未披露,未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
2
位分析师
买入
评级
3.750
目标均价
+312.27%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议
Rockwell Medical Inc亮点
亮点风险
Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.
Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.
公司代码RMTI
公司Rockwell Medical Inc
CEOStrobeck (Mark)
网址https://www.rockwellmed.com/
常见问题
Rockwell Medical Inc(RMTI)的当前股价是多少?
Rockwell Medical Inc(RMTI)的当前股价是 0.849。
Rockwell Medical Inc的股票代码是什么?
Rockwell Medical Inc的股票代码是RMTI。
Rockwell Medical Inc股票的52周最高点是多少?
Rockwell Medical Inc股票的52周最高点是2.410。
Rockwell Medical Inc股票的52周最低点是多少?
Rockwell Medical Inc股票的52周最低点是0.780。
Rockwell Medical Inc的市值是多少?
Rockwell Medical Inc的市值是33.46M。
Rockwell Medical Inc的净利润是多少?
Rockwell Medical Inc的净利润为-480.00K。
现在Rockwell Medical Inc(RMTI)的股票是买入、持有还是卖出?
根据分析师评级,Rockwell Medical Inc(RMTI)的总体评级为买入,目标价格为3.750。
Rockwell Medical Inc(RMTI)股票的每股收益(EPS TTM)是多少
Rockwell Medical Inc(RMTI)股票的每股收益(EPS TTM)是-0.164。